Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
52 studies found for:    "Raynaud Disease"
Show Display Options
Download search resultsDownload the search results for:
"Raynaud Disease" (52 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed Safety, Tolerability, and Pharmacodynamic Profile of Oral 2101 in Secondary Raynaud's Disease
Condition: Raynaud's Disease
Interventions: Drug: SLx-2101;   Drug: Placebo
2 Completed Nova Cold Hands Raynaud's Disorder, a Disease Which Results in Decreased Blood Flow to the Hands and Feet.
Condition: Raynaud's Disease
Intervention: Radiation: Nova Flow Procedure
3 Completed Dose Response Study of a Topical Formulation of Nitroglycerin for the Treatment of Raynaud's Phenomenon
Condition: Raynaud's Disease
Intervention: Drug: Nitroglycerin
4 Completed Phase III Study of Topical Gel for Treatment and Prevention of Raynaud's Phenomenon
Condition: Raynaud's Disease
Intervention: Drug: Topical organogel with nitroglycerin
5 Completed Effects of Vardenafil on Clinical Symptoms and Peripheral Blood Flow in Patients With Raynaud's Syndrome
Condition: Raynaud Syndrome
Interventions: Drug: vardenafil;   Drug: Placebo
6 Active, not recruiting A Two-Part Study of BOTOX® Therapy for Ischemic Digits
Condition: Raynaud's Disease
Intervention: Drug: onabotulinum toxin type-A
7 Completed Digital Flow Enhancement in Raynaud's Phenomenon With an sGC (Soluble Guanylate Cyclase) Stimulator
Condition: Raynaud Disease
Interventions: Drug: Riociguat (Adempas, BAY63-2521);   Drug: Placebo
8 Unknown  Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms
Condition: Raynaud Disease
Interventions: Drug: 0.9% nitroglycerin in TAM cream;   Drug: vehicle cream
9 Unknown  Efficacy and Tolerability of Ginkgo Biloba Extract in Patients With Raynaud´s Phenomenon
Condition: Raynaud Disease
Intervention: Drug: Ginkgo biloba extract EGb 761®
10 Recruiting Diosmiplex (Vasculera®) in Primary and Secondary Raynaud's Phenomenon
Condition: Raynaud's Disease
Interventions: Other: placebo;   Dietary Supplement: diosmiplex
11 Completed St. John's Wort in the Treatment of Raynaud's Phenomenon
Condition: Raynaud's Disease
Interventions: Drug: St. John's Wort;   Drug: Lactose
12 Completed Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud’s Phenomenon
Condition: Raynaud's Disease
Intervention: Drug: Pletal
13 Completed Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud’s Phenomenon
Condition: Raynaud's Disease
Intervention: Drug: Pletal
14 Completed Randomised Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma
Condition: Raynaud Disease
Intervention: Drug: Tadalafil
15 Active, not recruiting Efficacy of Botulinum Toxin In Scleroderma-Associated Raynaud's Syndrome
Conditions: Scleroderma;   Raynaud's Syndrome
Interventions: Drug: Onabotulinumtoxin A;   Drug: sterile saline solution
16 Completed
Has Results
Botulinum Toxin in the Treatment of Raynaud's
Condition: Raynaud's Syndrome
Intervention: Drug: botulinum toxin A
17 Enrolling by invitation A Trial of Ischemic Preconditioning in Raynaud's Phenomenon (RP)
Conditions: Raynaud Disease;   Raynaud's Phenomenon
Intervention: Device: Manual blood pressure cuff inflation over brachial artery
18 Completed Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis
Conditions: Systemic Sclerosis;   Raynaud Disease
Intervention: Drug: iloprost
19 Completed Laser Speckle Contrast Imaging for Cutaneous Microvascular Dysfunction Detection in Systemic Sclerosis.
Conditions: Raynaud Disease;   Scleroderma, Systemic
Interventions: Procedure: laser speckle contrast imaging;   Procedure: Cooling
20 Completed PF-00489791 For The Treatment Of Raynaud's
Conditions: Raynaud's Disease;   Peripheral Vascular Disease
Intervention: Drug: PF-00489791

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.